Literature DB >> 7532544

TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation.

J Sang1, Y P Lim, M Panzica, P Finch, N L Thompson.   

Abstract

Hepatocellular carcinoma is characterized by changes in gene expression associated with cell growth and differentiation. Cell surface antigenic changes have also been described based on differential antibody reactivity between normal and neoplastic liver. We obtained a novel tumor-associated cDNA designated TA1 on the basis of its differential expression between hepatoma cells and normal liver. Sequence analysis predicted a 723-base pair open reading frame with the deduced amino acid sequence encoding an integral membrane protein containing multiple hydrophobic transmembrane domains. Database searches revealed TA1 as the likely rat homologue of E16, a recently cloned human cDNA associated with lymphocyte activation. Although noncoding sequences diverged significantly, the 95% conservation of the predicted proteins between species strongly suggests an important, although as yet undefined, function in normal cells. TA1 transcripts were detected in normal adult rat tissues including testes, brain, ovary, spleen, mammary gland, and uterus with the highest steady-state expression in placenta. Although no expression was detected in normal liver, all rat hepatomas examined expressed an abundant 3.2-kilobase transcript. TA1 expression was closely associated with progression in this tumor model and suggests this molecule, originally linked to cell activation, also plays a role in the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532544

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  LAT1 overexpression and function compensates downregulation of ASCT2 in an in vitro model of renal proximal tubule cell ageing.

Authors:  Maria João Pinho; José Miguel Cabral; Elisabete Silva; Maria Paula Serrão; Patrício Soares-da-Silva
Journal:  Mol Cell Biochem       Date:  2010-12-02       Impact factor: 3.396

2.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

3.  Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation.

Authors:  T Nii; H Segawa; Y Taketani; Y Tani; M Ohkido; S Kishida; M Ito; H Endou; Y Kanai; E Takeda
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

4.  Selective expression of the large neutral amino acid transporter at the blood-brain barrier.

Authors:  R J Boado; J Y Li; M Nagaya; C Zhang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 5.  The role of CD98 in astrocytic neoplasms.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

6.  L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Gregory S Robinson; Maureen J Bourner; Christopher T Bauer; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

7.  Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Authors:  Kuniaki Nakanishi; Sho Ogata; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Shinsuke Aida; Hiroyasu Kasamatsu; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2007-07-11       Impact factor: 4.064

8.  LAT-1 expression in pre- and post-implantation embryos and placenta.

Authors:  M K Chrostowski; B G McGonnigal; J P Stabila; J F Padbury
Journal:  Placenta       Date:  2009-02-04       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.